Article citationsMore>>

J. C. Yang, J. Y. Shih, W. C. Su, T. C. Hsia, C. M. Tsai, S. H. Ou, et al., “Afatinib for Patients with Lung Adenocarcinoma and Epidermal Growth Factor Receptor Mutations (LUX-Lung 2): A Phase 2 Trial,” Lancet Oncology, Vol. 13, No. 5, 2012, pp. 539-548. doi:10.1016/S1470-2045(12)70086-4

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2025 Scientific Research Publishing Inc. All Rights Reserved.
Top